Arnd Kaltofen-Ehmann
Director/Board Member at Inositec AG
Network origin in Arnd Kaltofen-Ehmann first degree
Entity | Entity type | Industry | |
---|---|---|---|
VI Partners AG
VI Partners AG Investment ManagersFinance VI Partners AG (VI Partners) is an independent venture capital firm founded in 2001. The firm is headquartered in Schwyz, Switzerland.
11
| Private Company | Investment Managers | 11 |
Araris Biotech AG
Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany.
6
| Holding Company | Pharmaceuticals: Other | 6 |
Inositec AG
Inositec AG Pharmaceuticals: MajorHealth Technology Inositec AG develops small molecules as alternatives to antibiotics. It also develops a non-antibiotic small molecule that neutralizes the toxins secreted by clostridium toxins. The company was founded by Mattias Ivarsson, Bastien Castagner and Jean-Christophe Leroux in December 2015 and is headquartered in Zurich, Switzerland.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Arnd Kaltofen-Ehmann via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
VECTURA GROUP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Sonogene LLC | Director/Board Member | ||
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Founder | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member | |
Chicago Center for Clinical Research
Chicago Center for Clinical Research Miscellaneous Commercial ServicesCommercial Services Part of CRA Holdings LLC, Chicago Center for Clinical Research is an American company that provides clinical research services. The company was founded by Michael H. Davidson. | Miscellaneous Commercial Services | Chief Executive Officer | |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Corporate Officer/Principal | |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
University of Basel | College/University | Graduate Degree Doctorate Degree | |
University of Zurich | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
University of Lausanne | College/University | Undergraduate Degree Doctorate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Masters Business Admin Doctorate Degree | |
BURCKHARDT COMPRESSION HOLDING AG | Industrial Machinery | Director/Board Member | |
American College of Chest Physicians
American College of Chest Physicians Miscellaneous Commercial ServicesCommercial Services The American College of Chest Physicians is a leading organization in clinical chest medicine, with over 19,000 members providing patient care in pulmonary, critical care, and sleep medicine in more than 100 countries worldwide. The non-profit company is based in Northbrook, IL. The organization offers access to clinical guidelines, new research, and clinical topic collections through their website, as well as opportunities for members to become more involved in the chest medicine community. The organization's mission is to promote the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. Robert A. Musacchio has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Medical/Nursing Services | Corporate Officer/Principal | |
Preventive Cardiology Institute, Inc. | Director/Board Member | ||
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
GSF-National Research Center for Environment & Health GmbH | Chief Tech/Sci/R&D Officer | ||
Hochschule RheinMain | College/University | Undergraduate Degree | |
Abcentra, Inc.
Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Abcentra, Inc. is an American clinical-stage biopharmaceutical company that specializes in developing novel antibody therapies for inflammatory diseases, with a particular focus on cardiovascular disease. The private company's patented technology allows for the targeting of oxidized lipoproteins and associated inflammatory responses. Abcentra's pipeline focuses on patient populations with high-risk of cardiometabolic complications that are exacerbated by chronic inflammation, including patients with inflammatory diseases and patients with residual inflammation. The company's lead compound, orticumab, is a novel monoclonal antibody that blocks inflammation from oxidized low-density lipoprotein and is slated to begin a phase 2 study later this year. Kevin B. Bacon has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Burckhardt Compression AG
Burckhardt Compression AG Electronic Equipment/InstrumentsElectronic Technology Burckhardt Compression AG manufactures reciprocating compressor technologies. It offers compressor solutions to the upstream oil and gas, gas transport and storage, refinery, petrochemical and chemical and industrial gas sectors. The firm’s services include valve reconditioning, spare parts logistics, field service, technical support, component repair, revamps and upgrades, trainings, and condition monitoring and diagnostics. The company was founded in 1844 and is headquartered in Winterthur, Switzerland. | Electronic Equipment/Instruments | Director/Board Member | |
Mckinsey & Co., Inc. (Switzerland) | Corporate Officer/Principal Corporate Officer/Principal | ||
Inamed GmbH
Inamed GmbH Medical/Nursing ServicesHealth Services Inamed GmbH engages in the development of drug inhalation systems and therapies. Its products include organic fiber and fiber products; nondiagnostic biological products; medical instruments; surgical appliances; and supplies. The company was founded by Thomas Meyer and Gerhard Scheuch in 1998 and is headquartered in Gauting, Germany. | Medical/Nursing Services | Founder | |
Emch AG | Director/Board Member | ||
MKP-Consulting AG | Corporate Officer/Principal | ||
Advanced Circuit Pursuit AG | Chairman | ||
Pierrel Research Onco-Immunology GmbH | Director of Finance/CFO | ||
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer | |
HealthUp Sp zoo
HealthUp Sp zoo Packaged SoftwareTechnology Services HealthUp Sp zoo develops MySpiroo -a mobile spirometer, which is a handheld, portable, wireless, smartphone connected medical device. The company was founded on August 19, 2014 and is headquartered in Warsaw, Poland. | Packaged Software | Director/Board Member | |
The University of Chicago Department of Medicine | College/University | Corporate Officer/Principal | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
NewAmsterdam Pharma Holding BV
NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Chief Executive Officer | |
Jocasta Neuroscience, Inc.
Jocasta Neuroscience, Inc. BiotechnologyHealth Technology Jocasta Neuroscience, Inc. provides biological products development services. The company is based in New Castle, DE. | Biotechnology | Director/Board Member | |
NanoPhoria Srl
NanoPhoria Srl Drugstore ChainsRetail Trade NanoPhoria Srl is an Italian company that operates as a non-viral drug delivery platform. The company is based in Milan, Italy. The company was founded by Daniele Catalucci, Michele Iafisco, Alessio Alogna, Claudio de Luca. Claudio de Luca has been the CEO since incorporation. | Drugstore Chains | Director/Board Member | |
Trofi Nutritionals, Inc.
Trofi Nutritionals, Inc. Specialty StoresRetail Trade Trofi Nutritionals, Inc. is a private company located in the US that is focused on advancing personal health management through next-generation nutritional wellness solutions. The American company works with partners to translate functional compound discoveries into nutritional solutions. | Specialty Stores | Founder | |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
SonoThera, Inc.
SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation. | Pharmaceuticals: Other | Founder | |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Chairman Corporate Officer/Principal Founder Director of Finance/CFO | |
National Lipid Association
National Lipid Association Miscellaneous Commercial ServicesCommercial Services The National Lipid Association aims to improve the practice of lipid management in clinical medicine. The non-profit company is based in Jacksonville, FL and has subsidiaries in the United States. The organization's mission is to enhance lipid management in clinical medicine, and its goals are consistent with this mission statement. | Miscellaneous Commercial Services | President | |
Midwest Lipid Association | Director/Board Member | ||
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
United States | 22 |
Switzerland | 12 |
Germany | 9 |
United Kingdom | 4 |
Netherlands | 4 |
Sectoral
Health Technology | 16 |
Consumer Services | 12 |
Commercial Services | 7 |
Health Services | 4 |
Retail Trade | 3 |
Operational
Director/Board Member | 110 |
Corporate Officer/Principal | 36 |
Founder | 21 |
Private Equity Investor | 15 |
Chairman | 14 |
Most connected contacts
Insiders | |
---|---|
Michael Davidson | 27 |
Monika Krüsi Schädle | 21 |
Alain Nicod | 17 |
Christian Schneider | 17 |
Dominik Escher | 15 |
Diego Braguglia | 13 |
Michael Sidler | 13 |
Andreas Wallnöfer | 10 |
Dmitry Kuzmin | 9 |
Frank Lehmann | 9 |
Gerhard Scheuch | 8 |
Daniel Gutenberg | 8 |
Zoltán Czigler | 7 |
Michael Wacker | 7 |
Holger Heims | 6 |
- Stock Market
- Insiders
- Arnd Kaltofen-Ehmann
- Company connections